Perrigo | PRGO - Selling And Administration Expenses


Perrigo reported $267.3M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Abbott USD 3.6B 330M Jun/2026
Bayer EUR 3.7B 356M Mar/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Corcept Therapeutics USD 156.9M 28.85M Jun/2026
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Eli Lilly USD 2.93B 198M Mar/2026
J&J USD 6.42B 381M Jun/2026
Merck USD 2.67B 180M Mar/2026
Nestle CHF 12.33B 133M Jun/2026
Pacira USD 83.88M 7.99M Mar/2026
Perrigo USD 267.3M 11.4M Mar/2026
Pfizer USD 3.41B 496M Jun/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 30.28M 606K Mar/2026
Sanofi EUR 2.63B 307M Jun/2026
Supernus Pharmaceuticals USD 133.64M 15.41M Jun/2026
Teva Pharmaceutical Industries USD 1.03B 34M Jun/2026
Xeris Pharmaceuticals USD 53.14M 10.51M Mar/2026
Zoetis USD 588M 31M Mar/2026